MedTrace Logo

Imaging Whole Coronary Artery With Intravascular Ultrasound (Ivus) And Imap For Plaque Tissue Composition In Patients With Acute Myocardial Infarction

NCT01437553 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-07-01

No results posted yet for this study

Summary

The iWONDER trial has the following objective:

To analyze the morphological, phenotypic and tissue characteristics of atherosclerotic plaques angiographically considered "culprit" and "not-culprit" in patients undergoing coronary angiography due to STEMI (ST-elevation myocardial infarction).

Conditions

  • Acute Coronary Syndrome

Interventions

DEVICE

iMAP

IVUS and iMAP analysis for acute coronary syndromes

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Adriano M Caixeta, PhD · Federal University of São Paulo

  • Cristiano F Souza, MD · Federal University of São Paulo

  • Antonio C Carvalho, PhD · Federal University of São Paulo

  • Claudia M Alves, PhD · Federal University of São Paulo

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-03-31
Completion
2013-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01437553 on ClinicalTrials.gov